Display options
Cite
Wefel JS. Choosing clinical trial endpoints, aggregating data, and making clinical decisions. Neurooncol Pract. 2017;4(4):199-200doi: 10.1093/nop/npx032.
Wefel, J. S. (2017). Choosing clinical trial endpoints, aggregating data, and making clinical decisions. Neuro-oncology practice, 4(4), 199-200. https://doi.org/10.1093/nop/npx032
Wefel, Jeffrey S. "Choosing clinical trial endpoints, aggregating data, and making clinical decisions." Neuro-oncology practice vol. 4,4 (2017): 199-200. doi: https://doi.org/10.1093/nop/npx032
Wefel JS. Choosing clinical trial endpoints, aggregating data, and making clinical decisions. Neurooncol Pract. 2017 Dec;4(4):199-200. doi: 10.1093/nop/npx032. Epub 2017 Dec 01. PMID: 31385989; PMCID: PMC6655419.
Copy Download .nbib Format: NLM
Share it on

Neurooncol Pract. 2017 Dec;4(4):199-200. doi: 10.1093/nop/npx032. Epub 2017 Dec 01.

Choosing clinical trial endpoints, aggregating data, and making clinical decisions.

Neuro-oncology practice

Jeffrey S Wefel

Affiliations

  1. Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center.

PMID: 31385989 PMCID: PMC6655419 DOI: 10.1093/nop/npx032

[No abstract available.]

Publication Types